About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
click here to read more
Post navigation
Previous Post
Phosphagenics Appoints Three New Directors
Next Post
Appendix 3X Notices – Three New Directors
Related Posts
Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
October 21, 2021
Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch
May 17, 2016
Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan
August 22, 2017